Table 2.
Outcome | Low glucosinolate Mean (95%CI) | High glucosinolate Mean (95%CI) | p-value |
---|---|---|---|
ITC synovial fluid (nM) | n.d | 496.6 (419.10 to 574.20) | — |
ITC plasma (fold change) | 0.90 (0.68 to 1.12) | 2.20 (1.45 to 2.92) | <0.0001 |
SFN plasma (change) | 0.02 (−0.01 to 0.04) | 0.32 (0.2 to 0.44) | <0.0001 |
ITC plasma (µM) baseline | 1.71 (1.10 to 2.33) | 1.17 (0.69 to 1.64) | — |
ITC plasma (µM) post intervention | 1.36 (0.86 to 1.87) | 2.22 (1.19 to 3.24) | — |
SFN plasma (µM) baseline | n.d | 0.004 (−0.004 to 0.012 | — |
SFN plasma (µM) post intervention | 0.02 (−0.005 to 0.04) | 0.32 (0.20 to 0.44) | — |
Total isothiocyanates (ITCs) measured in synovial fluid and plasma, and the specific metabolite sulforaphane (SFN) measured in plasma from low and high glucosinolate groups. Fold change: post intervention/baseline, Change: post intervention – baseline, low glucosinolate n = 20, high glucosinolate n = 17, n.d – not detected. Mean values with 95% confidence intervals and p-values are given.